These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28892015)

  • 1. The Road to Hell Is Paved with Good Intentions: Why Harm-Benefit Analysis and Its Emphasis on Practical Benefit Jeopardizes the Credibility of Research.
    Grimm H; Eggel M; Deplazes-Zemp A; Biller-Andorno N
    Animals (Basel); 2017 Sep; 7(9):. PubMed ID: 28892015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necessary, but Not Sufficient. The Benefit Concept in the Project Evaluation of Animal Research in the Context of Directive 2010/63/EU.
    Eggel M; Grimm H
    Animals (Basel); 2018 Feb; 8(3):. PubMed ID: 29495562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harm-Benefit Analysis May Not Be the Best Approach to Ensure Minimal Harms and Maximal Benefits of Animal Research-Alternatives Should Be Explored.
    Gutfreund Y
    Animals (Basel); 2020 Feb; 10(2):. PubMed ID: 32059540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reviewing the Review: A Pilot Study of the Ethical Review Process of Animal Research in Sweden.
    Jörgensen S; Lindsjö J; Weber EM; Röcklinsberg H
    Animals (Basel); 2021 Mar; 11(3):. PubMed ID: 33807898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly-A Practical Guideline.
    Zintzsch A; Noe E; Grimm H
    Animals (Basel); 2020 May; 10(5):. PubMed ID: 32429139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mission impossible accomplished? A European cross-national comparative study on the integration of the harm-benefit analysis into law and policy documents.
    Hajosi D; Grimm H
    PLoS One; 2024; 19(2):e0297375. PubMed ID: 38377057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reevaluating Benefits in the Moral Justification of Animal Research: A Comment on "Necessary Conditions for Morally Responsible Animal Research".
    Eggel M; Neuhaus CP; Grimm H
    Camb Q Healthc Ethics; 2020 Jan; 29(1):131-143. PubMed ID: 31858941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case for integrity: gains from including more than animal welfare in animal ethics committee deliberations.
    Röcklinsberg H; Gamborg C; Gjerris M
    Lab Anim; 2014 Jan; 48(1):61-71. PubMed ID: 24367033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm-Benefit Analyses Can Be Harmful.
    Niemi SM
    ILAR J; 2021 Sep; 60(3):341-346. PubMed ID: 32785593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm-benefit analysis - what is the added value? A review of alternative strategies for weighing harms and benefits as part of the assessment of animal research.
    Grimm H; Olsson IAS; Sandøe P
    Lab Anim; 2019 Feb; 53(1):17-27. PubMed ID: 29966482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for Addressing Harm-Benefit Analysis and Implementation in Ethical Evaluation - Report from the AALAS-FELASA Working Group on Harm-Benefit Analysis - Part 2.
    Laber K; Newcomer CE; Decelle T; Everitt JI; Guillen J; Brønstad A
    Lab Anim; 2016 Jun; 50(1 Suppl):21-42. PubMed ID: 27188276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The upper limits of pain and suffering in animal research.
    Beauchamp TL; Morton DB
    Camb Q Healthc Ethics; 2015 Oct; 24(4):431-47. PubMed ID: 26364778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A defense of 'risk-benefit' terminology.
    Kinter LB; Johnson DK
    Lab Anim (NY); 2015 Oct; 44(10):403-7. PubMed ID: 26398615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capable and credible? Challenging nutrition science.
    Penders B; Wolters A; Feskens EF; Brouns F; Huber M; Maeckelberghe ELM; Navis G; Ockhuizen T; Plat J; Sikkema J; Stasse-Wolthuis M; van 't Veer P; Verweij M; de Vries J
    Eur J Nutr; 2017 Sep; 56(6):2009-2012. PubMed ID: 28718015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese villages and their sustainable future: the European Union-China-Research Project "SUCCESS".
    Dumreicher H
    J Environ Manage; 2008 Apr; 87(2):204-15. PubMed ID: 17888563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidance on determining indispensability and balancing potential benefits of animal experiments with costs to the animals with specific consideration of EU directive 2010/63/EU.
    Lindl T; Gross U; Ruhdel I; von Aulock S; Völkel M
    ALTEX; 2012; 29(2):219-28. PubMed ID: 22562491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Road to Uncreative Science Is Paved With Good Intentions: Ideas, Implementations, and Uneasy Balances.
    Kaufman JC; Glǎveanu VP
    Perspect Psychol Sci; 2018 Jul; 13(4):457-465. PubMed ID: 29961418
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.